| Synonyms: | |
| Status: | Approved (1998) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N06AB04 |
| UNII: | 0DHU5B8D6V |
| InChI Key | WSEQXVZVJXJVFP-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H21FN2O |
| Molecular Weight | 324.4 |
| AlogP | 3.81 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 36.26 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 24.0 |
| Property Name | Value | Unit | Method |
|---|---|---|---|
| log P (octanol-water) | 3.740 | - | EST |
| Atmospheric OH Rate Constant | 9.21E-11 | cm3/molecule-sec | EST |
| Primary Target | |
|---|---|
| SERT |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 73300 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 10-3981 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Voltage-gated calcium channel
|
- | 64500 | - | - | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
- | - | - | 50119 | - | |
|
Membrane receptor
|
- | - | - | 292 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
8700 | 6-90000 | - | 2-33 | 58-89 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 18800 | - | - | 52 | |
|
Unclassified protein
|
- | - | - | 5410 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Depressive Disorder | 4 | D003866 | ClinicalTrials |
| Depressive Disorder | 4 | D003866 | ClinicalTrials |
| Obsessive-Compulsive Disorder | 3 | D009771 | ClinicalTrials |
| Schizophrenia | 3 | D012559 | ClinicalTrials |
| Anxiety | 3 | D001007 | ClinicalTrials |
| Dementia | 3 | D003704 | ClinicalTrials |
| Psychomotor Agitation | 3 | D011595 | ClinicalTrials |
| Depressive Disorder, Major | 3 | D003865 | ClinicalTrials |
| Bipolar Disorder | 2 | D001714 | ClinicalTrials |
| Alcoholism | 2 | D000437 | ClinicalTrials |
| Irritable Bowel Syndrome | 2 | D043183 | ClinicalTrials |
| Panic Disorder | 2 | D016584 | ClinicalTrials |
| Parkinson Disease | 2 | D010300 | ClinicalTrials |
| Opioid-Related Disorders | 2 | D009293 | ClinicalTrials |
| Alcoholism | 2 | D000437 | ClinicalTrials |
| Stroke | 2 | D020521 | ClinicalTrials |
| Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
| Acute Coronary Syndrome | 1 | D054058 | ClinicalTrials |
| Child Development Disorders, Pervasive | 1 | D002659 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 59729-33-8 |
| ChEBI | 77397 |
| ChEMBL | CHEMBL549 |
| DrugBank | DB00215 |
| DrugCentral | 663 |
| EPA CompTox | DTXSID8022826 |
| FDA SRS | 0DHU5B8D6V |
| Human Metabolome Database | HMDB0005038 |
| Guide to Pharmacology | 4621 |
| KEGG | C07572 |
| PharmGKB | PA449015 |
| PubChem | 2771 |
| SureChEMBL | SCHEMBL946 |